Juul Pays Massive Settlement to End Youth Vaping Probe
According to the Associated Press, Juul Labs will pay nearly $440 million to settle a two-year investigation by 33 U.S. states into the marketing of its vaping products, which critics said fueled a surge in underage vaping. Investigators found that Juul p
According to the Associated Press, Juul Labs will pay nearly $440 million to settle a two-year investigation by 33 states in the U.S. regarding the marketing of its e-cigarette products, which critics say has led to a surge in youth vaping.<\/div>
<\/div>
The investigation found that Juul marketed its e-cigarettes to underage teens through parties, product giveaways, advertisements, and social media posts featuring young models.<\/div>
<\/div>
“Through this settlement, we are obtaining hundreds of millions of dollars to help reduce nicotine use and forcing Juul to accept a series of strict injunction terms to end youth marketing and combat underage sales,” Connecticut Attorney General William Tong stated in a release on September 6.<\/div>
<\/div>
In fact, most of the restrictions imposed by the settlement will not affect Juul's practices, as the company stopped using parties, giveaways, and other promotional activities after coming under scrutiny a few years ago.<\/div>
<\/div>
While Juul's early marketing focused on young urban consumers, the company has since shifted to positioning its products as an alternative nicotine source for older smokers.<\/div>
<\/div>
The company stated: “We will continue to focus on our future as we fulfill our mission to keep adult smokers away from cigarettes, the leading cause of preventable death, while combating youth usage.”<\/div>
<\/div>
While resolving one of its biggest legal threats, Juul Labs still faces nine separate lawsuits from other states. Additionally, Juul is facing hundreds of individual lawsuits filed by teenagers and others who claim they became addicted to the company's e-cigarette products.<\/div>
<\/div>
The company is also appealing the marketing denial order (MDO) from the U.S. Food and Drug Administration, which, if upheld, would force its products off the market.<\/div>
<\/div>
In June, the FDA rejected Juul Labs' premarket tobacco product application, stating that the evidence submitted by the company was insufficient to demonstrate that its products were appropriate for the protection of public health.<\/div>
<\/div>
Although the agency later paused its MDO, citing scientific issues that needed further review in the application, it emphasized that the pause does not revoke the order.<\/div>
